Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Adamas Pharmaceuticals- Inc. (ADMS)

21.84 -0.59 (-2.63%)

08-20 16:00

Open:

22.37

Pre. Close:

22.43

High:

22.785

Low:

21.4

Volume:

637,988

Market Cap:

594M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

22.824 - 22.954

22.954 - 23.094

Low:

21.051 - 21.189

21.189 - 21.339

Close:

21.576 - 21.819

21.819 - 22.084

Technical analysis  (as of: 2018-08-20 4:35:53 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 30.83     One year: 34.44

Support:

Support1: 21.40    Support2: 17.80

Resistance:

Resistance1: 26.40    Resistance2: 29.49

Pivot:

23.68

Moving Averages:

MA(5): 22.54     MA(20): 24.29

MA(100): 26.77     MA(250): 27.56

MACD:

MACD(12,26): -1.02     Signal(12,26,9): -0.81

%K %D:

%K(14,3): 11.83     %D(3): 14.11

RSI:

RSI(14): 32.85

52-Week:

High: 44  Low: 13.85  Change(%): 52.7

Average Vol(K):

3-Month: 56662  10-Days 61933

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ADMS has closed above bottom band by 6.1%. Bollinger Bands are 7.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-08-03T20:32:06-04:00
Adamas Pharmaceuticals, Inc. (ADMS) Gregory Went on Q2 2018 Results - Earnings Call Transcript

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Drug Manufacturers - Specialty Generic

Shares Out. (M)

27.19

Shares Float (M)

26.72

% Held by Insiders

1.70

% Held by Institutions

Shares Short (K)

8185

Shares Short Prior Month (K)

Stock Financials

EPS

-4.920

EPS Est. Current Year

-3.770

EPS Est. Next Year

-3.420

EPS Est. Next Quarter

-1.170

Forward EPS

-3.948

Book Value (p.s.)

4.360

PEG Ratio

-0.12

Profit Margin

Operating Margin

-1052.44

Return on Assets (ttm)

-57.1

Return on Equity (ttm)

-98.7

Qtrly Rev. Growth

378150.0

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.786

Qtrly Earnings Growth

Operating Cash Flow (M)

-97.59

Levered Free Cash Flow (M)

-63.64

Valuation

P/E

-4.44

P/E Growth Ratio

-0.03

P/BV

5.01

P/S

1380999040.00

P/CF

-6.09

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.